Biogen sees flat 2024 sales, pick up in Alzheimer’s drug demand
By Manas Mishra and Sriparna Roy (Reuters) -Biogen on Tuesday forecast flat 2024 product…
N2:HECA
Moderna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debut
(Reuters) - Shares of Metagenomi Technologies, a genetic medicines company backed by…
Pfizer posts surprise 4th quarter profit, but key products miss on…
By Michael Erman and Bhanvi Satija (Reuters) -Pfizer reported a surprise quarterly profit…
Global money market funds see third weekly inflow ahead of US…
(Reuters) - Global investors accumulated money market funds for a third straight week in…
Pharmacy chain Walgreens cuts dividend to save cash, shares slump
By Bhanvi Satija and Mariam Sunny (Reuters) -Walgreens Boots Alliance on Thursday nearly…
McKinsey to pay $78 million in US opioid settlement with health plans
By Nate Raymond (Reuters) - Consulting firm McKinsey & Co has agreed to pay $78…
Bayer wins latest Roundup cancer trial, ending losing streak
By Brendan Pierson (Reuters) - Bayer has won a trial in a lawsuit brought by a California…
Investors retreated from global bond funds on caution ahead of Fed…
(Reuters) - Investors pulled back sharply from global bond funds in the seven days…
Cigna abandons pursuit of Humana, plans $10 billion share buyback…
By Anirban Sen (Reuters) -U.S. health insurer Cigna has ended its attempt to negotiate an…
Johnson & Johnson forecasts as much as 6% sales growth in 2024
By Patrick Wingrove and Bhanvi Satija (Reuters) -Johnson & Johnson on Tuesday…